Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Update on the therapeutic benefits of quetiapine in psychological disorders

Nov. 7, 2005

Novel agents for the treatment of neurological disorders disclosed in recent patents

Nov. 7, 2005

SL-650155 reveals effects of serotonin in models of amnesia

Nov. 7, 2005

Positive outcome for BEMA-fentanyl in comparative pharmacokinetics study

Nov. 7, 2005

Spinocerebellar ataxia type 5 caused by spectrin SPTBN2 mutations

Nov. 4, 2005

New treatment options for neuropsychiatric disorders claimed in recent patent literature

Nov. 4, 2005

Melanocortin receptor agonist emerges from Astellas Pharma R&D

Nov. 4, 2005

Clinical data supports the use of extended-release methylphenidate in ADHD

Nov. 4, 2005

Maruho to develop and market DepoBupivacaine in Japan

Nov. 4, 2005

Adderall XR improves symptoms and quality of life of adult patients with ADHD

Nov. 4, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...